
    
      Using a mixed-methods design, this study will be completed in three phases. For Phase 3, we
      aim to conduct a randomized control trial with 400 patients with pre-diabetic, all of whom
      will be using the dDPP application. Half of enrolled patients will be randomized to the
      intervention group and receive automated targeted messaging.
    
  